These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35904642)

  • 1. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome.
    Seravalle G; Vanoli J; Molisano C; Merati V; Grassi G
    Acta Diabetol; 2022 Nov; 59(11):1429-1435. PubMed ID: 35904642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure.
    Grassi G; Seravalle G; Vanoli J; Facchetti R; Spaziani D; Mancia G
    Clin Res Cardiol; 2023 Jan; 112(1):59-67. PubMed ID: 35552503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated heart rate as sympathetic biomarker in human obesity.
    Seravalle G; Facchetti R; Cappellini C; Annaloro A; Gelfi E; Grassi G
    Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2367-2374. PubMed ID: 35970685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease.
    Grassi G; Fowler B; Scali B; Rossi F; Motto E; Pieruzzi F; Mancia G
    J Hypertens; 2022 Aug; 40(8):1530-1536. PubMed ID: 35792492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Facchetti R; Mancia G
    Hypertension; 2020 Aug; 76(2):577-582. PubMed ID: 32594806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
    Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
    J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate as a sympathetic marker during acute adrenergic challenge.
    Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
    J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies.
    Quarti Trevano F; Dell'Oro R; Biffi A; Seravalle G; Corrao G; Mancia G; Grassi G
    J Hypertens; 2020 Apr; 38(4):565-572. PubMed ID: 32132429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited reliability of heart rate as a sympathetic marker in chronic kidney disease.
    Dell'Oro R; Quarti-Trevano F; Seravalle G; Bertoli S; Lovati C; Mancia G; Grassi G
    J Hypertens; 2021 Jul; 39(7):1429-1434. PubMed ID: 33394867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity.
    Grassi G; Seravalle G; Dell'Oro R; Arenare F; Facchetti R; Mancia G
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):469-75. PubMed ID: 19157817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs.
    Grassi G; Seravalle G; Stella ML; Turri C; Zanchetti A; Mancia G
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):29-34. PubMed ID: 10678268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure.
    Velez-Roa S; Renard M; Degaute JP; van de Borne P
    J Am Coll Cardiol; 2003 Nov; 42(9):1605-10. PubMed ID: 14607447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking is associated with chronic sympathetic activation in hypertension.
    Hering D; Kucharska W; Kara T; Somers VK; Narkiewicz K
    Blood Press; 2010 Jun; 19(3):152-5. PubMed ID: 20429695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting sympathetic outflow does not predict the morning blood pressure surge in hypertension.
    Hering D; Kucharska W; Kara T; Somers VK; Narkiewicz K
    J Hypertens; 2011 Dec; 29(12):2381-6. PubMed ID: 21986622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback effects of circulating norepinephrine on sympathetic outflow in healthy subjects.
    Tulppo MP; Huikuri HV; Tutungi E; Kimmerly DS; Gelb AW; Hughson RL; Mäkikallio TH; Shoemaker JK
    Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H710-5. PubMed ID: 15471979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of graded LBNP on MSNA and interstitial norepinephrine.
    Khan MH; Sinoway LI; MacLean DA
    Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H2038-44. PubMed ID: 12384483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA
    Teixeira AL; Fernandes IA; Vianna LC
    J Physiol; 2019 Aug; 597(16):4139-4150. PubMed ID: 31247674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate as marker of sympathetic activity.
    Grassi G; Vailati S; Bertinieri G; Seravalle G; Stella ML; Dell'Oro R; Mancia G
    J Hypertens; 1998 Nov; 16(11):1635-9. PubMed ID: 9856364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.
    Leimbach WN; Wallin BG; Victor RG; Aylward PE; Sundlöf G; Mark AL
    Circulation; 1986 May; 73(5):913-9. PubMed ID: 3698236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.